Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
van Bodegraven AA, Bravenboer N, Witte BI, Dijkstra G, van der Woude CJ, Stokkers PC, Russel MG, Oldenburg B, Pierik M, Roos JC, van Hogezand RA, Dik VK, Oostlander AE, Netelenbos JC, van de Langerijt L, Hommes DW, Lips P; Dutch Initiative on Crohn and Colitis (ICC).
van Bodegraven AA, et al. Among authors: bravenboer n.
Gut. 2014 Sep;63(9):1424-30. doi: 10.1136/gutjnl-2013-305523. Epub 2013 Oct 21.
Gut. 2014.
PMID: 24146170
Clinical Trial.